Atlas Trials

Immunovant Sciences GmbH

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Immunovant Sciences GmbH

RecordFirmDate
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) (NCT07286006)Immunovant Sciences GmbH2026-01-26
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT07188844)Immunovant Sciences GmbH2025-08-28
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity (NCT06979531)Immunovant Sciences GmbH2025-06-30
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease (NCT07018323)Immunovant Sciences GmbH2025-06-19
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis (NCT07039916)Immunovant Sciences GmbH2025-05-27
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT07032662)Immunovant Sciences GmbH2025-03-18
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) (NCT06980805)Immunovant Sciences GmbH2025-02-19
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis (NCT06754462)Immunovant Sciences GmbH2025-01-10
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease (NCT06727604)Immunovant Sciences GmbH2024-12-17
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease (NCT05907668)Immunovant Sciences GmbH2023-05-15
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease (NCT05524571)Immunovant Sciences GmbH2023-01-05
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP (NCT05581199)Immunovant Sciences GmbH2022-12-15
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease (NCT05517421)Immunovant Sciences GmbH2022-11-23
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease (NCT05517447)Immunovant Sciences GmbH2022-11-06
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis (NCT05403541)Immunovant Sciences GmbH2022-06-27
To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). (NCT04253236)Immunovant Sciences GmbH2020-08-11
ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) (NCT03938545)Immunovant Sciences GmbH2019-07-23
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients (NCT03863080)Immunovant Sciences GmbH2019-05-21
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) (NCT03922321)Immunovant Sciences GmbH2019-04-22

Track Immunovant Sciences GmbH automatically

Every clearance here is in the API, with alerts when new ones post.